Decompensated cirrhosis requires continuous monitoring

CirrhoCare® enables clinicians to assess a patient's condition remotely almost in real-time, allowing informed assessment and timely interventions

About CirrhoCare

CirrhoCare® enables clinicians to assess a patient's condition remotely almost in real-time, allowing informed assessment and timely interventions

Decompensation usually leads to regular hospitalisation

Any one of several complications can give rise to an acute event. However, studies show that a significant proportion of these re-admissions are preventable with continual monitoring, but there are currently no approved? means of doing this with the patient in a home setting. Deterioration usually occurs quite quickly, well within the time between scheduled clinical reviews

How It works

  • CirrhoCare® utilises a smartphone app that collates the patient's vital metrics for transmission on to the CyberLiver platform for analysis
  • CirrhoCare® also acts as bi-directional communication system between hepatologists and their patients, helping to ensure compliance and engagement
  • The patient effectively receives specialist care on a continual basis, regardless of location or proximity to specialised liver care centres
  • The patient's status is presented in real-time to clinicians via a dashboard, raising alerts whenever algorithms analysing the various metrics indicate the onset or worsening of specific complications
  • The CirrhoCare® dashboard enables specialists and nursing staff to make rapid, informed interventions, either to treat the complication or triage the patient for acute care

Benefits of CirrhoCare

  • CirrhoCare detects early signs of new decompensation complications and alerts for timely intervention
  • CirrhoCare® also acts as bi-directional communication system between hepatologists and their patients, helping to ensure compliance and engagement
  • CirrhoCare managed patients have opportunity for reduced disease morbidity and severity
  • CirrhoCare managed patients have improvement in their quality of life
Logo mt-30

Intented use

CirrhoCare is a digital therapeutic intended for assisted diagnosis, recommendations and therapeutic intervention for the management of new complications of decompensated cirrhosis.

Indications for Use

CirrhoCare will be applied for out-of-hospital specialist Hepatology follow-up and intervention of all adult cirrhosis patients, at risk of acute cirrhosis decompensation. Its principle use is foreseen in patients being discharged from hospital following recovery from acute cirrhosis decompensation, for assisted diagnosis of new complications of cirrhosis and their early intervention. As such, potentially preventable causes of cirrhosis decompensation when diagnosed, such as dehydration or hepatic encephalopathy, would be managed by a prescription digital therapeutic intervention by CirrhoCare. In patients who remain stable on CirrhoCare Management follow-up for up to 6 months, a more standard medium-term outpatient clinical follow-up pathway could be resumed. For those, who remain unstable or with signs of frequent new complications, CirrhoCare PDT management would be continued beyond 6 months..

Contact

Whether you are a healthcare provider, a clinical trial partner, an ARLD patient or a user who wants to reduce your alcohol consumption and gain access to AlcoChange or support along your journey, we are here to help.

Customer Support

If you are an already existing customer or have technical or other issues, our experts are ready to help.

Email us